Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
5.26
+0.06 (1.15%)
Apr 14, 2026, 4:00 PM EDT - Market closed

Journey Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
144209871113493
Market Cap Growth
5.10%141.61%-22.18%226.31%-63.39%-
Enterprise Value
145.07210.4991.3198.524.9944.89
Last Close Price
5.267.713.915.761.925.38
PE Ratio
--16.40-5.43-27.43-1.14-1.25
PS Ratio
2.323.381.541.410.461.48
PB Ratio
4.486.574.325.472.012.22
P/TBV Ratio
4.055.933.985.161.981.30
P/FCF Ratio
--16.82-9.4921.24-2.52-42.72
P/OCF Ratio
--16.82-9.4921.24-2.52-42.72
EV/Sales Ratio
2.353.401.631.240.340.71
EV/EBITDA Ratio
--55.02-8.9955.27-1.08-1.39
EV/EBIT Ratio
--25.76-6.68-47.51-0.91-1.29
EV/FCF Ratio
--16.92-10.0018.80-1.85-20.58
Debt / Equity Ratio
0.790.791.250.721.350.02
Debt / EBITDA Ratio
-6.64-6.64-2.478.27-0.99-0.03
Debt / FCF Ratio
-2.09-2.04-2.752.81-1.70-0.42
Net Debt / Equity Ratio
0.040.040.24-0.62-0.53-1.15
Net Debt / EBITDA Ratio
-0.34-0.34-0.47-7.130.391.49
Net Debt / FCF Ratio
-0.11-0.10-0.52-2.420.6722.09
Asset Turnover
0.710.710.710.870.730.85
Inventory Turnover
1.741.741.691.882.565.70
Quick Ratio
1.441.440.871.020.901.40
Current Ratio
1.791.791.371.351.161.64
Return on Equity (ROE)
-44.03%-44.03%-72.60%-20.64%-100.39%-168.13%
Return on Assets (ROA)
-9.40%-9.40%-17.49%-2.42%-27.24%-48.56%
Return on Invested Capital (ROIC)
-27.96%-27.96%-75.83%-16.10%-295.83%-326.03%
Return on Capital Employed (ROCE)
-15.99%-15.99%-34.17%-5.66%-65.52%-100.35%
Earnings Yield
-7.95%-6.10%-18.41%-3.65%-88.02%-80.30%
FCF Yield
-8.65%-5.94%-10.54%4.71%-39.68%-2.34%
Buyback Yield / Dilution
-19.90%-19.90%-12.06%-4.00%-72.15%6.02%
Total Shareholder Return
-19.90%-19.90%-12.06%-4.00%-72.15%6.02%
Updated Mar 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q